Efficacy and Safety of XP12B in Women With Menorrhagia

PHASE3CompletedINTERVENTIONAL
Enrollment

304

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

May 31, 2008

Study Completion Date

May 31, 2008

Conditions
MenorrhagiaHeavy Menstrual Bleeding
Interventions
DRUG

Tranexamic acid tablets

3900 mg/Day

DRUG

Tranexamic acid tablets

1950 mg/Day

DRUG

Placebo tablets

Trial Locations (83)

10017

Investigative Site, New York

14621

Investigative Site, Rochester

15090

Investigative Site, Wexford

19056

Investigative Site, Levittown

19087

Investigative Site, Strafford

19096

Investigative Site, Wynnewood

19104

Investigative Site, Philadelphia

19114

Investigative Site, Philadelphia

19460

Investigative Site, Phoenixville

21230

Investigative Site, Baltimore

23225

Investigative Site, Richmond

23502

Investigative Site, Norfolk

27103

Investigative Site, Winston-Salem

27607

Investigative Site, Raleigh

27713

Investigative Site, Durham

29605

Investigative Site, Greenville

30033

Investigative Site, Decatur

30328

Investigative Site, Atlanta

32216

Investigative Site, Jacksonville

32610

Investigative Site, Gainesville

33064

Investigative Site, Lighthouse PT

33141

Investigative Site, Miami Beach

33186

Investigative Site, Miami

34233

Investigative Site, Sarasota

34652

Investigative Site, New Port Richey

35209

Investigative Site, Birmingham

37043

Investigative Site, Clarksville

37203

Investigative Site, Nashville

37620

Investigative Site, Bristol

43701

Investigative Site, Zanesville

44121

Investigative Site, Cleveland

44122

Investigative Site, Cleveland

45631

Investigative Site, Gallipolis

46502

Investigative Site, Temple

47403

Investigative Site, Bloomington

48025

Investigative Site, Bingham Farms

48081

Investigative Site, Saint Clair Shores

48106

Investigative Site, Ann Arbor

49079

Investigative Site, Paw Paw

49506

Investigative Site, Grand Rapids

57104

Investigative Site, Sioux Falls

58501

Investigative Site, Bismarck

59808

Investigative Site, Missoula

64114

Investigative Site, Kansas City

66215

Investigative Site, Overland Park

67114

Investigative Site, Newton

69001

Investigative Site, McCook

70072

Investigative Site, Marrero

72143

Investigative Site, Searcy

72205

Investigative Site, Little Rock

73104

Investigative Site, Oklahoma City

73112

Investigative Site, Oklahoma City

75093

Investigative Site, Plano

76132

Investigative Site, Fort Worth

76712

Investigative Site, Waco

77030

Investigative Site, Houston

77380

Investigative Site, The Woodlands

77598

Investigative Site, Webster

77802

Investigative Site, Bryan

78737

Investigative Site, Austin

80202

Investigative Site, Denver

83404

Investigative Site, Idaho Falls

83712

Investigative Site, Boise

84062

Investigative Site, Pleasant Grove

84088

Investigative Site, West Jordan

84120

Investigative Site, West Valley City

84124

Investigative Site, Salt Lake City

85015

Investigative Site, Phoenix

85710

Investigative Site, Tucson

85712

Investigative Site, Tucson

87131

Investigative Site, Albuquerque

89128

Investigative Site, Las Vegas

90027

Investigative Site, Los Angeles

90720

Investigative Site, Los Alamitos

92108

Investigative Site, San Diego

97205

Investigative Site, Portland

97401

Investigative Site, Eugene

98055

Investigative Site, Renton

06340

Investigative Site, Groton

08648

Investigative Site, Lawrenceville

08057

Investigative Site, Moorestown

08903

Investigative Site, New Brunswick

05401

Investigative Site, Burlington

Sponsors
All Listed Sponsors
lead

Ferring Pharmaceuticals

INDUSTRY